glutamic acid and metformin

glutamic acid has been researched along with metformin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	2 (28.57)	29.6817
2010's	2 (28.57)	24.3611
2020's	2 (28.57)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Beylot, M; Large, V	1
Batandier, C; Detaille, D; El-Mir, MY; Fontaine, E; Guigas, B; Leverve, XM; Rigoulet, M	1
Arakaki, RF; Florez, JC; Goldstein, BJ; Hanson, RL; Jablonski, KA; Kahn, SE; Kitabchi, AE; Knowler, WC; Mason, CC; McAteer, JB; Moore, AF	1
Cui, Y; Du, Y; Gu, H; Jiang, Y; Li, S; Liu, Q; Sun, C; Sun, R; Xiao, Y; Zhou, C; Zhuang, S	1
Alolayan, SO; Alomar, SY; Atef, H; El-Shafey, M; Elaskary, AA; Eldosoky, M; Elhawary, R; Elkazaz, AY; Gabr, AM; M Barakat, B; Mohamed, AS; Salih, MAK; Youssef, AM; Zaitone, SA	1
Abdellatif, AAH; Aldubayan, MA; Alhowail, AH; Almogbel, YS; Chigurupati, S; Nemala, RA	1

Trials

1 trial(s) available for glutamic acid and metformin

Article	Year
The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:2 Topics: Chromans; Combined Modality Therapy; Diabetes Mellitus, Type 2; Exercise Therapy; Female; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Glutamic Acid; Humans; Hypoglycemic Agents; Incidence; Lysine; Male; Metformin; Middle Aged; Phosphoric Diester Hydrolases; Polymorphism, Single Nucleotide; Pyrophosphatases; Risk Reduction Behavior; Thiazolidinediones; Troglitazone	2009

Article

Year

The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program.

The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:2

Topics: Chromans; Combined Modality Therapy; Diabetes Mellitus, Type 2; Exercise Therapy; Female; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Glutamic Acid; Humans; Hypoglycemic Agents; Incidence; Lysine; Male; Metformin; Middle Aged; Phosphoric Diester Hydrolases; Polymorphism, Single Nucleotide; Pyrophosphatases; Risk Reduction Behavior; Thiazolidinediones; Troglitazone

2009

Other Studies

6 other study(ies) available for glutamic acid and metformin

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin. Diabetes, 1999, Volume: 48, Issue:6 Topics: Animals; Citric Acid Cycle; Diabetes Mellitus, Experimental; Gluconeogenesis; Glucose; Glutamic Acid; Hypoglycemic Agents; In Vitro Techniques; Lactic Acid; Liver; Male; Metformin; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Starvation; Streptozocin	1999
The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin. Journal of bioenergetics and biomembranes, 2006, Volume: 38, Issue:1 Topics: 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Electron Transport; Electron Transport Complex I; Glutamic Acid; Hypoglycemic Agents; In Vitro Techniques; Malates; Malonates; Membrane Potentials; Metformin; Mitochondria, Liver; Oxidation-Reduction; Phosphorylation; Rats; Rats, Wistar; Reactive Oxygen Species; Rotenone; Succinic Acid	2006
Metformin prevents cerebellar granule neurons against glutamate-induced neurotoxicity. Brain research bulletin, 2016, Volume: 121 Topics: Animals; Animals, Newborn; Apoptosis; Caspase 3; Cells, Cultured; Cerebellum; Cytochromes c; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Glutamic Acid; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Metformin; Neurons; Neuroprotective Agents; Rats	2016
Protective effect of metformin on rat diabetic retinopathy involves suppression of toll-like receptor 4/nuclear factor-k B expression and glutamate excitotoxicity. International immunopharmacology, 2021, Volume: 90 Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glutamic Acid; Hypoglycemic Agents; Male; Metformin; NF-kappa B; Oxidative Stress; Rats, Wistar; Retina; Signal Transduction; Streptozocin; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2021
Effects of CMF and MET on glutamate and dopamine levels in the brain, and their impact on cognitive function. European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:7 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Breast Neoplasms; Cognition; Cyclophosphamide; Diabetes Mellitus, Type 2; Dopamine; Female; Fluorouracil; Glutamic Acid; Humans; Metformin; Methotrexate; Rats	2022